Descrizione Clinica
Bench drugs Normogin 6cpr vag 40mg Laboratori Baldacci
NORMOGIN – 40 MG COMPRESSE VAGINALI
active ingredients
Each vaginal tablet contains: Active ingredient: lyophilized culture of selected strain of Döderlein mg bacillus 40 (Lactobacillus rhamnosus) BMX 54 ≥ 4 X 104 CFU). Excipient: lactose mg 946, magnesium stearate mg 14.Excellent
Lactose monohydrate, magnesium stearate.Therapeutic indications
Vaginitis associated with ovarian insufficiency, hypofollicolinic leucorrea, infant vaginiti, senile vaginiti, vulvarious itching, vaginal dystrophy. Helpful in chemotherapy and antibiotic treatment of vaginitis from Trichomonas.Contraindications
Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1.Population
1 vaginal tablet, 1 or 2 times a day, to be introduced in the vagina.Conservation
Store between 2nd C and 8th C.Warnings
NORMOGIN does not replace antibiotic or chemotherapy therapy, but represents a useful complement, restoring, especially at the end of the specific treatment, the physiological conditions of the vaginal environment.Interactions
Not known.Effects
Undesirable effects related to product use have not been reported. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.agenziafarmaco.gov.it/it/responsabili.Overdosing
No known effects to be attributed to overdose.Döderlein's bacillus is a regular non-pathogenic host of the vagina, so NORMOGIN can be used during pregnancy or breastfeeding.
Source: Farmadati
